English
French
Press Release
|
26 |
Dec 2018 |
IntelGenx Grants Restricted Share Units... |
|
12 |
Dec 2018 |
IntelGenx Partners with Gensco® Pharma to Market RIZAPORT® in the United States... |
|
05 |
Dec 2018 |
IntelGenx Reports Amendment of Stock Option Plan... |
|
30 |
Nov 2018 |
IntelGenx Engages Focus Communications for Investor Relations Program... |
|
27 |
Nov 2018 |
IntelGenx Begins Montelukast VersaFilm™ Dosing in Patients with Mild to Moderate Alzheimer’s Disease in Phase 2a Stu... |
|
20 |
Nov 2018 |
IntelGenx Announces FDA’s Acceptance of Resubmission of New Drug Application for RIZAPORT®... |
|
13 |
Nov 2018 |
IntelGenx Closes Private Placement Financing... |
|
08 |
Nov 2018 |
IntelGenx Reports Third Quarter 2018 Financial Results... |
|
07 |
Nov 2018 |
IntelGenx Announces Definitive Agreement with Tilray® to Form an Exclusive, Worldwide Partnership for Cannabis-Infused ... |
|
01 |
Nov 2018 |
IntelGenx to Report Third Quarter 2018 Financial Results on November 8, 2018 – Conference Call to Follow... |
|
31 |
Oct 2018 |
The Spanish Agency of Medicines and Medical Devices Grants Marketing Authorization of RIZAPORT®... |
|
26 |
Oct 2018 |
IntelGenx Announces Exercise of Over-Allotment Option... |
|
22 |
Oct 2018 |
IntelGenx Completes US$12 Million Equity Offering... |
|
18 |
Oct 2018 |
IntelGenx Announces Pricing of $12 Million Equity Offering... |
|
17 |
Oct 2018 |
IntelGenx Receives Over $1.6 Million from Exercise of Warrants... |
|
17 |
Oct 2018 |
IntelGenx Announces Proposed Equity Offering... |
|
04 |
Oct 2018 |
IntelGenx Partner Insud Pharma Submits ANDA for Co-Developed Generic Buccal Film Product... |
|
25 |
Sep 2018 |
Patient Recruitment to Commence in IntelGenx’s Phase 2a Montelukast VersaFilm™ Trial in Mild to Moderate Alzheimer... |
|
24 |
Sep 2018 |
IntelGenx Announces Successful Results from RIZAPORT® Bioequivalence Study... |
|
20 |
Sep 2018 |
IntelGenx Signs Letter of Intent with Tilray® to Enter Into a World-Wide Agreement To Produce Cannabis-Infused VersaFil... |
|
30 |
Aug 2018 |
IntelGenx to Present at the 20th Annual Rodman & Renshaw Global Investment Conference... |
|
09 |
Aug 2018 |
IntelGenx Reports Second Quarter 2018 Financial Results... |
|
02 |
Aug 2018 |
IntelGenx to Report Second Quarter 2018 Financial Results on Aug 9, 2018 – Conference Call to Follow... |
|
05 |
Jul 2018 |
IntelGenx Receives CIPO Notice of Allowance for Loxapine VersaFilm™ Patent... |
|
19 |
Jun 2018 |
IntelGenx Announces Notice of Grant of European Patent Covering Rizaport® VersaFilm™... |
|
14 |
Jun 2018 |
IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures... |
|
11 |
Jun 2018 |
IntelGenx Grants Stock Options... |
|
06 |
Jun 2018 |
Article in Alzheimer's & Dementia Points to an Additional Unmet Medical Need Targeted by IntelGenx’ Montelukast VersaF... |
|
15 |
May 2018 |
Performance and Restricted Share Unit Plan Approved by IntelGenx Technologies Corp. Shareholders... |
|
14 |
May 2018 |
IntelGenx Announces Settlement of Suboxone® Patent Litigation... |
|
10 |
May 2018 |
IntelGenx Reports First Quarter 2018 Financial Results... |
|
08 |
May 2018 |
IntelGenx Closes Private Placement Financing... |
|
03 |
May 2018 |
IntelGenx to Report First Quarter 2018 Financial Results on May 10, 2018 – Conference Call to Follow... |
|
27 |
Apr 2018 |
IntelGenx to Present at the 2018 Bloom Burton & Co. Healthcare Investor Conference... |
|
29 |
Mar 2018 |
IntelGenx Reports Fourth Quarter and Full-Year 2017 Financial Results... |
|
27 |
Mar 2018 |
IntelGenx Announces Update on Private Placement and Proposed LaboVal Acquisition... |
|
23 |
Mar 2018 |
IntelGenx to Report Fourth Quarter and Full-Year 2017 Financial Results on March 29, 2018 – Conference Call to Follow... |
|
12 |
Mar 2018 |
IntelGenx Clarifies Recent Preliminary 2018 Proxy Statement Filing... |
|
26 |
Jan 2018 |
IntelGenx Mourns the Passing of long term Director Ian Troup... |
|
24 |
Jan 2018 |
IntelGenx Initiates Phase 2A Montelukast Versafilm™ Clinical Trial in Alzheimer’s Patients... |
|
04 |
Jan 2018 |
IntelGenx To Present at Biotech Showcase™ 2018... |